Este trabajo presenta los resultados del aislamiento de micoplasmas respiratorios en ganado vacuno de Bosnia Herzegovina entre los años 2002 y 2010. Se analizaron 328 hisopos nasales y 59 muestras de pulmón remitidas para el aislamiento de micoplasmas. Un total de 27 muestras resultaron positivas (6.9%). Se identificó la presencia de M. bovis en 8 hisopos y 2 pulmones, mientras que M. bovirhinis (n=4) y Acholeplasma sp. (n=1) se detectaron en hisopos nasales. Doce aislamientos de micoplasma (44.4%) no pudieron ser identificados con los métodos habituales de diagnóstico.
in respiratory disease. This study represents Mycoplasma species isolated from the respiratory tract of cattle population in B&H between 2002 and 2010.
MATERIAL AND METHODS
A total of 328 nasal swabs and 59 lung samples were collected from cattle from various regions in B&H. The nasal swabs were obtained from 221 animals showing no signs of disease and 107 with clinical signs of respiratory infection. Lung samples were collected only from cattle with clinical signs of respiratory infection. All samples were cultured in liquid and solid media (Thiaucourt et al., 1996) and incubated in a 95% N 2 and 5% CO 2 humidified atmosphere at 37°C. Preliminary identification of the isolates was performed using culture morphology (Gourlay et al., 1983) and biochemical examination (sensitivity to digitonin, fermentation of glucose, hydrolysis of arginine, phosphatase activity, film and spots
INTRODUCTION
Bovine respiratory disease is the most common illness affecting housed cattle worldwide. Mycoplasmas cause some of the most serious and economically most costly respiratory diseases of cattle. Contagious bovine pleuropneumonia, caused by M. mycoides subsp. mycoides small colony (SC) is the only bacterial disease classified by the Office International des Epizooties as a list A disease (Nicholas et al., 2008) . Mycoplasma bovis is the most pathogenic bovine mycoplasma in the parts of the world that are free of contagious bovine pleuropneumonia (Nicholas et al., 2003 (Table  1) were performed in a GeneAmp PCR System 2700 thermal cycler (Applied Biosystems), in a total volume of 25 µl. DNA samples were prepared as described by Tola et al. (1997) with some modifications. Briefly, 200 ml of each isolate were incubated for 10 min at room temperature with 100 ml of denaturation buffer (0.5 M NaOH, 1.5 M NaCl) and then for a further 10 min at room temperature with 40 µ1 of silica particles suspended in 900 µ1 of lysis buffer (10.12 M guanidine isothiocyanate, 0.1 M Tris-HCl, pH 6.4, 0.11 M EDTA, pH 8.0, 2.6% Triton X-100). After centrifugation at 12,000 x g for 15 s, the pellet was washed twice with washing buffer (10.12 M guanidine isothiocyanate, 0.1 M Tris-HCl, pH 6.4), twice with 70% ethanol and once with acetone. The dried pellet was then resuspended in 100 m1 of TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0), heated at 56 ºC for 10 min, briefly vortexed and centrifuged at 12,000 x g for 2 min. 5 µ1 of supernatant were added to the reaction mixture for amplification. Amplified samples were analysed by electrophoresis in a 1.5 per cent agarose gel. The gel was then stained with ethidium bromide and examined under a transilluminator (Vilber Lourmat).
RESULTS
A total of 27 samples were positive for mycoplasmas (6.9%). Mycoplasmas were isolated from 22 of the 328 nasal swabs and five of the 59 lung samples. In accordance to animal health status, mycoplasmas were found in 7 (3.16%) of 221 nasal swabs from asymptomatic animals and 15 (14%) from symptomatic animals. M. bovis was recovered from ten samples (37%), and most strains (n=8) were isolated from nasal swabs. All M. bovis strains were isolated from the symptomatic cattle. M. bovirhinis was identified in 14.8% nasal swabs from asymptomatic cattle and one nasal swab was positive for Acholeplasma sp. (3.7%). Twelve mycoplasma isolates were identified by PCR only to the level of class (Mollicutes) ( Table 2 ).
DISCUSSION
M. bovis was the most common mycoplasma species isolated during the research period. In this study, it was recovered only from cattle showing clinical signs of respiratory infection, although the presence of M. bovis in the upper respiratory tract of healthy cattle has been reported (Feenstra et al., 1991; Ter Laak et al., 1992) . The identification rate of M. bovis in the present study (37% of the isolates) is lower than that reported by Ayling et al. (2004) and Chazel et al. (2010) , who obtained isolation rates of 52% and 55% of the isolates, respectively. The relatively low isolation rate in this study may be associated with the use of antibiotic therapy before sampling, or clinical status of the cattle (Thomas et al., 2002) . The most common antibiotics used in B&H against respiratory infection of cattle are fluoroquinolones and tetracyclines. The both groups of antibiotics are well known as inhibitors of mycoplasmas and that additionally support possibilities of their negative impact to isolation process in this study. Failure to identified two isolate of M. bovis (01/02 and 14/10) in this study by GIT could be conducted with antigen variability of this species. Interesting finding is that arthritis or mastitis caused by this mycoplasma was not reported during this research. It is particularly important for mastitis which is one of the most serious and economically most costly diseases of dairy cattle worldwide (Gonzalez et al., 2003) . Other pathogenic mycoplasmas were not identified, but one strain showed cultural and biochemical characteristics typical for M. dispar. For this species it has been shown to cause pneumonia following experimental infection, although the disease produced is not severe (Nicholas et al., 2008) . In contrast to M. bovis, M. bovirhinis was isolated only from cattle showing no signs of disease. This mycoplasma can be found in the upper and lower respiratory tracts of both healthy and diseased cattle. It is not believed to be a primary pathogen but may exacerbate existing disease conditions caused by other pathogens (Nicholas et al., 2008) .
The presence of M. bovis in animals with clinical respiratory disease provides the opportunity for this organism to be spread and to cause severe disease, and underscores the need to develop control measures to combat respiratory diseases in cattle. Based on the results obtained in this study, we believe that most important control measures that should be used in B&H are quarantine and control of all new animals, prior their introduction in the farm. Also, new cattle should be bought in the areas free of M. bovis. Further studies are required to identify other mycoplasma isolates.
